Definition
Biological aging is the progressive cellular and physiological deterioration that accompanies the passage of time in living organisms, distinct from chronological age, which simply measures elapsed time since birth.
Why it matters
Biological aging is the underlying process that produces increasing mortality risk with age — it is what makes lifetime income arrangements economically meaningful at all. Naming the process matters for understanding why mortality is not uniform across individuals of the same chronological age and why some individuals deviate substantially from population averages.
How it works
Biological aging unfolds across multiple levels — cellular, tissue, organ, organismal — through interconnected processes that have been the subject of intensive biomedical research over the past several decades. At the cellular level, processes include progressive damage to DNA, shortening of chromosomal telomeres, dysfunction of mitochondria, accumulation of damaged proteins, and exhaustion of the stem cell populations responsible for tissue renewal. At the systemic level, these cellular changes produce declining function in cardiovascular, immune, neurological, and metabolic systems, which in turn produce the increasing probability of disease and death observed in mortality tables. The 2013 López-Otín synthesis identified nine hallmarks of aging — and the 2023 update expanded the list to twelve — providing a systematic taxonomy of the cellular and molecular mechanisms involved. The rate at which biological aging proceeds varies across individuals of the same chronological age, which is what makes biological age a separately measurable concept from chronological age.
In practice
For an individual, biological aging is what the popular discourse about longevity, healthspan, and aging interventions is ultimately about — the underlying process whose rate determines the years of life lived and the years lived in good health. The distinction between biological and chronological age matters in lifetime income planning because individuals who are biologically older than their chronological age (due to chronic disease, lifestyle factors, or genetic predisposition) face shorter expected lifespans, while those biologically younger may live considerably longer than population mortality tables predict. A professional advising on retirement income generally cannot directly measure biological age — current commercial biological age tests are not standardized actuarial instruments — but the concept underlies the broader question of how an individual's specific mortality outlook differs from the population average. Medically underwritten lifetime income products do attempt to translate biological-age-related factors (medical history, current health status, smoking, certain laboratory values) into individualized mortality assumptions, but they do so through traditional underwriting rather than through biological-age measurement directly.
In the Longevity Standard Framework
Biological aging is supporting vocabulary in the Longevity Standard framework. The framework's actuarial engine prices mortality through a Gompertz parameterization with Society of Actuaries credibility scaling — it operates on chronological age and demographic mortality tables, not on biological-age inputs directly. Biological aging remains relevant as the basis that produces the mortality patterns the framework measures, and as the analytical territory in which future framework extensions could in principle incorporate biological-age proxies where they become standardized enough for actuarial use.
Related terms
- Senescence
- Hallmarks of aging
- Biological age versus chronological age
- Epigenetic clock
- Mortality rate
- Life expectancy
- Healthspan versus lifespan
- Gompertz law